Jennifer Bath | Chief Executive Officer |
Barry Duplantis | Vice President-Client Relations |
Ilse Roodink | Chief Scientific Officer |
Brad McConn | Chief Financial Officer |
Swayampakula Ramakanth | H.C. Wainwright |
Michael Freeman | Raymond James |
Will McHale | Ingalls & Snyder |
Good morning and thank your standing by. Welcome to ImmunoPrecise Antibody’s Second Quarter Fiscal Year 2023 Earnings Conference Call. Also on the call with us today are Jennifer Bath, Chief Executive Officer; Brad McConn, Chief Financial Officer; Ilse Roodink, Chief Scientific Officer; and Barry Duplantis, Vice President of Client Relations.
Before we get started, remember some statements we make today may be considered forward-looking statements for the purposes of applicable United States and Canadian securities laws. IPA cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements.